Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This is a Phase 1b, randomized, double-blind, placebo-controlled trial to evaluate the
safety, tolerability, and pharmacokinetic profiles of voriconazole inhalation powder in adult
subjects with well-controlled asthma. This study will involve 2 cohorts.